A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : AA / alopecia areata

[Related PubMed/MEDLINE]
Total Number of Papers: 890
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   AA  (>> Co-occurring Abbreviation)
Long Form:   alopecia areata
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A 'hair-raising' history of alopecia areata. ---
2020 Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity. HADS, IL, PsA
2020 Association of Autoimmune Regulator Gene Rs2075876 Variant, but Not Gene Expression with Alopecia Areata in Males: A Case-control Study. AIRE, PCR, qRT-PCR
2020 Authors' reply to: Comment on the article by Dr. Toshima about alopecia areata multiplex following autologous dermal micrograft injection. AGA
2020 Benefit and risk profile of tofacitinib for the treatment of alopecia areata: a systemic review and meta-analysis. ---
2020 Efficacy and Influence Factors of 308-nm Excimer Lamp with Minoxidil in the Treatment of Alopecia Areata. ---
2020 Harnessing the Power of Regenerative Therapy for Vitiligo and Alopecia Areata. ---
2020 JAK inhibition in the treatment of alopecia areata - a promising new dawn? JAK
2020 Overlapping and Distinct FAS/FASLG Gene Polymorphisms in Alopecia Areata in an Iranian Population. FASLG
10  2020 Plasmacytoid dendritic cells as a possible key player to initiate alopecia areata in the C3H/HeJ mouse. IFN, pDCs
11  2020 Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study. ---
12  2020 The profile of cytokines (IL-2, IFN-gamma, IL-4, IL-10, IL-17A, and IL-23) in active alopecia areata. ---
13  2019 'The psychosocial burden of alopecia areata and androgenetica': a cross-sectional multicentre study among dermatological out-patients in 13 European countries. AGA, QOL
14  2019 A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata. PDE4, SALT
15  2019 A Study of the Histopathological Features of Alopecias on Transverse Sections of Scalp Biopsies. AGA, DLE, FD, LPP
16  2019 Allergy promotes alopecia areata in a subset of patients. HDMs
17  2019 Alopecia Areata Different View; Heavy Metals. Cd, Co, Mn, Zn
18  2019 Alopecia areata in Tunisia: epidemio-clinical aspects and comorbid conditions. A prospective study of 204 cases. APECED
19  2019 Alopecia areata patients show deficiency of FOXP3+CD39+ T regulatory cells and clonotypic restriction of Treg TCRbeta-chain, which highlights the immunopathological aspect of the disease. ---
20  2019 Alopecia areata: a long-term follow-up study of 104 patients. ---
21  2019 Alteration of serum and tissue tumor necrosis factor alpha levels: A possible mechanism of action of oral pulse steroids in the treatment of alopecia areata. TNF-alpha
22  2019 Apremilast in Refractory Alopecia Areata. ---
23  2019 Are Preferred Scalp Locations for Alopecia Areata Patches a Clue to Neuronal Etiology? ---
24  2019 Assessment of a Bidirectional Association Between Major Depressive Disorder and Alopecia Areata. MDD
25  2019 Assessment of Metabolic Profile and Ischemia-modified Albumin Level in Patients with Alopecia Areata: A Case-Control Study. IMA, sdLDL
26  2019 Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target. AAP, DEGs, GEO, GO, KEGG, PPI
27  2019 Blood endotyping distinguishes the profile of vitiligo from that of other inflammatory and autoimmune skin diseases. AD, CLA
28  2019 Candidate Gene Analysis Of Alopecia Areata In Jordanian Population Of Arab Descent: A Case-Control Study. SNPs
29  2019 Cellular retinol-binding protein-1 expression increases with increasing clinical severity of alopecia areata. HC, RA
30  2019 Chronological association between alopecia areata and autoimmune thyroid diseases: A systematic review and meta-analysis. AITD, TgAb, TPOAb
31  2019 Clinico-Dermoscopic Pattern of Beard Alopecia Areata: A Cross-Sectional Study. BAA
32  2019 Combination of photodynamic therapy with 5-aminolaevulinic acid and microneedling in the treatment of alopecia areata resistant to conventional therapies: our experience with 41 patients. ALA, MN, PDT
33  2019 Combined intravenous pulse and topical corticosteroid therapy for severe alopecia areata in children: Comparison of two regimens. 3-DP, AAP, GR, HT
34  2019 Comorbidities in alopecia areata: A systematic review and meta-analysis. ---
35  2019 Complementary & Alternative Medicine for Alopecia Areata: A Systematic Review. CAM
36  2019 Cyclosporine for moderate-to-severe alopecia areata: A double-blind, randomized, placebo-controlled clinical trial of efficacy and safety. ---
37  2019 Dickkopf-1 Expression in Androgenetic Alopecia and Alopecia Areata in Male Patients. AGA, DKK1
38  2019 Differential expression patterns of specific long noncoding RNAs and competing endogenous RNA network in alopecia areata. ceRNA, ceRNA network, DEGs, DElncRNA, lncRNAs, miRNAs, mRNAs
39  2019 Distinguishing immunohistochemical features of alopecia areata from androgenic alopecia. AGA
40  2019 Does Immunosuppression Help Control Alopecia Areata? A Study in Transplant Recipients. ---
41  2019 Dupilumab and alopecia: A Janus effect. AD, IL-13, IL-4
42  2019 Efficacy and safety of anthralin in combination with diphenylcyclopropenone in the treatment of alopecia areata: a retrospective case series. DPCP
43  2019 Elevated serum tumour necrosis factor-like weak inducer of apoptosis in alopecia areata: a possible marker of disease severity. SALT, TWEAK
44  2019 Emerging Nonsteroid-Based Procedural Therapies for Alopecia Areata: A Systematic Review. PRP, UVR
45  2019 Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. ---
46  2019 Evaluation of complete blood cell and inflammatory parameters in patients with alopecia areata: Their association with disease severity. CBC, CRP, ESR, MPV, NLR, PCT, RDW, SALT
47  2019 Evaluation of platelet-rich plasma vs intralesional steroid in treatment of alopecia areata. ILCs, PRP, RGS
48  2019 Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata. OSI, PON1, TOS
49  2019 Evaluation of the Efficacy and Safety of 308-nm Monochromatic Excimer Lamp in the Treatment of Resistant Alopecia Areata. SALT, SD
50  2019 Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata. AU, SALT, TOFA
51  2019 Familial implications of autoimmune disease: Recurrence risks of alopecia areata and associated conditions in first-degree relatives. ---
52  2019 Family recurrence risk of alopecia areata in the Faroe Islands. RRR
53  2019 Feature characterization of scarring and non-scarring types of alopecia by multiphoton microscopy. AGA, FFA, MPM
54  2019 Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review. ---
55  2019 Frequency of the Types of Alopecia at Twenty-Two Specialist Hair Clinics: A Multicenter Study. AGA, FAPD, FD, FFA, LPP, SHC, TE
56  2019 Frontiers in alopecia areata pathobiology research. IP, NK
57  2019 HrQoL in hair loss-affected patients with alopecia areata, androgenetic alopecia and telogen effluvium: the role of personality traits and psychosocial anxiety. AGA, HRQoL, TE
58  2019 Identification of blood microRNA alterations in patients with severe active alopecia areata. miRNAs, mRNA
59  2019 Impact of cyclosporin treatment on health-related quality of life of patients with alopecia areata. AASIS, AQoL-8D, HRQoL, QOL
60  2019 Increased expression of TLR7 and TLR9 in alopecia areata. PBMCs, TLRs
61  2019 Increased Incidence of Thyroid Disease in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis. ---
62  2019 Inflammatory alopecia in patients on dupilumab: a retrospective cohort study at an academic institution. AD
63  2019 Integrative analysis of rare copy number variants and gene expression data in alopecia areata implicates an aetiological role for autophagy. CNVs, GE, GWAS
64  2019 Intralesional pentoxifylline injection in localized alopecia areata. PTX, TrA
65  2019 Ischemic modified albumin as a new biomarker in predicting oxidative stress in alopecia areata IMA
66  2019 Italian Guidelines in diagnosis and treatment of alopecia areata. ---
67  2019 JAK inhibitors for alopecia areata: a systematic review and meta-analysis. JAK
68  2019 Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study. JAK, SALT
69  2019 Janus kinase inhibitors: An innovative treatment for alopecia areata. JAK
70  2019 Living with alopecia areata: an online qualitative survey study. ---
71  2019 Longstanding patchy alopecia areata along the hairline, a variety of alopecia areata mimicking frontal fibrosing alopecia and other cases of hair loss. Case series of 11 patients. DIMES
72  2019 Macrophage migration inhibitory factor polymorphism (rs755622) in alopecia areata: a possible role in disease prevention. MIF
73  2019 Medicated thread moxibustion for alopecia areata: A case report. ---
74  2019 Meta-analysis of 308-nm excimer laser therapy for alopecia areata. FDA
75  2019 Methotrexate for alopecia areata: A systematic review and meta-analysis. ---
76  2019 Methotrexate in the treatment of paediatric alopecia areata: Retrospective case series and updated meta-analysis. MTX
77  2019 Minoxidil for patchy alopecia areata: systematic review and meta-analysis. RCTs
78  2019 morphological and immunohistochemical features of tissue homeostasis in patients with alopecia areata in the chronic stage associated with metabolic syndrome and the non-burdened course of the disease. ---
79  2019 Off-Label Use of Topical Minoxidil in Alopecia: A Review. CIA
80  2019 Oxidative stress in alopecia areata: a systematic review and meta-analysis. ---
81  2019 Pathogenesis of Alopecia Areata Based on Bioinformatics Analysis. BMP2, DEGs, KRTAPs, KRTs, MCODE
82  2019 Pathomechanisms of immune-mediated alopecia. HF, IP, PCA
83  2019 Patients with alopecia areata show signs of insulin resistance. FBS, HOMA-IR
84  2019 Perinevoid Alopecia: A Case Report. ---
85  2019 Platelet-Rich Plasma and Stem Cells for Hair Growth: A Review of the Literature. AGA
86  2019 Predictive factors of response to pulse methylprednisolone therapy in patients with alopecia areata: A follow-up study of 105 Japanese patients. AD
87  2019 Psychological Profile and Quality of Life of Patients with Alopecia Areata. cDLQI, DLQI, HADS, QOL, SALT
88  2019 Racial Characteristics of Alopecia Areata in the United States. CI, NAAR, OR
89  2019 Randomized controlled trial on a PRP-like cosmetic, biomimetic peptides based, for the treatment of alopecia areata. GFs, PRP
90  2019 Regulatory T-cells in alopecia areata. ---
91  2019 Remote-onset alopecia areata attributed to ipilimumab. CTLA-4, irAEs
92  2019 Response to ustekinumab in three pediatric patients with alopecia areata. ---
93  2019 Reversible alopecia areata: a little known side effect of leflunomide. DMARD, RA
94  2019 Scalp bacterial shift in Alopecia areata. ---
95  2019 Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata. AD, PRISMA-ScR
96  2019 Serum concentrations of selected proinflammatory cytokines in children with alopecia areata. ---
97  2019 Serum Interleukin-15 is a Marker of Alopecia Areata Severity. IL-15, SALT score
98  2019 Serum Vitamin D Levels and Alopecia Areata- A Hospital Based Case-Control Study from North-India. ---
99  2019 The Association between Genetic Variation in Wnt Transcription Factor TCF7L2 (TCF4) and Alopecia Areata. ---
100  2019 The association between rs2476601 polymorphism in PTPN22 gene and risk of alopecia areata: A meta-analysis of case-control studies. CNKI, NOS, ORs, PTPN22, SNP